Clinical Trial Update: A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler [Phase 2]

View source ↗

Summary

Phase 2 study assessing the acute bronchodilator effect of CHF1535 delivered via NEXThaler in patients with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CHF1535 NEXThaler (CHF1535)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED